RNA-based therapeutics have completely revolutionized the healthcare segment, greatly influencing the study and treatment of human diseases by conferring precise targeting ability to therapeutic modalities. Further, the enhanced safety and efficacy of treatment using RNA-based therapeutics has surpassed the safety profiles of the conventional treatment approaches. Considering their vast potential, stakeholders are actively engaged in